Our Belief

Sunniva is an ancient English name which means “Gift of the Sun”.

Sunniva is a vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. We are focused on the cultivation, production and distribution of a broad range of therapeutic solutions targeting two of the largest medical cannabis markets in the world: Canada and California. We operate through our wholly owned subsidiaries – Sunniva Medical Inc. (“SMI”), CP Logistics, LLC, Natural Health Services Ltd. And Full-Scale Distributors, LLC – and will offer a comprehensive range of white label solutions.

Our Belief

Sunniva is an ancient English name which means ‘Gift of the Sun”.

Sunniva is a vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. We are focused on the cultivation, production and distribution of a broad range of therapeutic solutions targeting two of the largest medical cannabis markets in the world: Canada and California. We operate through our wholly owned subsidiaries – Sunniva Medical Inc. (“SMI”), CP Logistics, LLC, Natural Health Services Ltd. And Full-Scale Distributors, LLC – and will offer a comprehensive range of white label solutions.

    ‍

“Our team is committed to improving the lives of as many patients as possible by providing access to safe, high-quality therapeutic cannabis products and services at scale. We will achieve this by attracting better talent, embracing better standards, and implementing better business practices.”

   ‍

   ‍

Dr. Anthony (Tony) Holler, Founder and CEO

https://www.youtube.com/watch?v=UmSNmTbF1ak

Meet The Founders

Sunniva was founded in 2014 by Dr. Anthony Holler and entrepreneur Leith Pederson to create a strong, diverse organization that could address the many challenges facing the emerging medical cannabis market. Hoping to be a guiding force in such a rapidly growing industry, they assembled a team of experts to develop better therapeutic products, better patient services, and better technology—building the Sunniva we know today.

Better Leadership

Sunniva’s Management Team

Dr. Anthony Holler

Chairman and CEO

Dr. Anthony (Tony) Holler is the former CEO and founder of ID Biomedical, acquired in 2015 by Glaxo Smith Kline for $1.7 billion, and former Chairman of Corriente Resources Inc., sold for approximately $700 million to CRCC-Tongguan Investment Co. Tony is the current Chairman of CRH Medical Corp., a publicly traded company and serves as Sunniva’s Chief Executive Officer. His expertise includes strategic planning, mergers and acquisitions, and financing, with a singular focus on increasing shareholder value.

Duncan Gordon

Chief Operating Officer

Duncan is the former head of manufacturing and supply chain management at Kudu Industries. With over 25 years experience as a manufacturing and supply chain expert, he has led various teams and large-scale projects focused on engineering, procurement, logistics, production and distribution.

Leith Pedersen

Co-Founder, President, Chief Strategy Officer & Director

As the former owner and CEO of Vida Wealth Management Bahamas, former investment advisor at Canaccord Wealth Management, and former partner at an Alberta brokerage firm managing capital in excess of $3 billion, Leith has a proven track record for success. He lends his expertise in corporate strategy, financing, and sourcing potential mergers and acquisitions.

Benjamin Rootman

VP, Legal, Compliance & Regulatory Affairs & Corporate Secretary

Ben is responsible for managing all aspects of the Company’s legal, compliance and regulatory functions and acts as Corporate Secretary to the Board of Directors. Previously, he was General Counsel and Corporate Secretary of Walton International Group Inc. (“WIGI”) from January 2017 to August 2017. Prior thereto, he held the role Chief Compliance Officer and Vice President, Law for Walton Capital Management Inc., a registered exempt market dealer, from July 2014 to January 2017 and the role of Legal Counsel for WIGI from July 2012 to July 2014. Before joining the Walton Group, he was an Associate at Burstall Winger Zammit LLP, focusing on corporate and securities law.

David Negus

Chief Financial Officer

David Negus has joined Sunniva Inc. as Chief Financial Officer and is accountable for the administrative, financial and risk management operations of the Company. Mr. Negus most recently served as the CFO of Luvo, a forward-thinking food company. Prior to his role at Luvo, Mr. Negus was Vice President, Corporate Controller at lululemon and played an integral role in the development and build out of a finance team that supported the business from a private company to a multi-billion dollar international organization. Mr. Negus holds a CPA, CA designation.

Daniel Vass

President & Founder of Natural Health Services Ltd.

Daniel is the founder and President of Natural Health Services (NHS), which operates boutique cannabis clinics across Canada with thousands of patients and growing. The NHS focuses on fulfilling underserved patient needs and educating on the importance of access to a physician-approved environment. NHS is a medical-centric corporation offering quality patient care, superior service and improved quality of life for its patients. NHS is grower-agnostic, choosing the finest products available at the best possible price.

Dr. Anthony Holler

Chairman and CEO

Dr. Anthony (Tony) Holler is the former CEO and founder of ID Biomedical, acquired in 2015 by Glaxo Smith Kline for $1.7 billion, and former Chairman of Corriente Resources Inc., sold for approximately $700 million to CRCC-Tongguan Investment Co. Tony is the current Chairman of CRH Medical Corp., a publicly traded company and serves as Sunniva’s Chief Executive Officer. His expertise includes strategic planning, mergers and acquisitions, and financing, with a singular focus on increasing shareholder value.

Leith Pedersen

Co-Founder, President, Chief Strategy Officer & Director

As the former owner and CEO of Vida Wealth Management Bahamas, former investment advisor at Canaccord Wealth Management, and former partner at an Alberta brokerage firm managing capital in excess of $3 billion, Leith has a proven track record for success. He lends his expertise in corporate strategy, financing, and sourcing potential mergers and acquisitions.

David Negus

Chief Financial Officer

David Negus is a recent addition as Chief Financial Officer (CFO). Negus has over 20 years of financial leadership most recently as CFO of Luvo, Inc., a forward-thinking food company. Previously, Negus was Vice President, Corporate Controller at lululemon athletica and led the finance team through their initial public offering. Mr. Negus received his Chartered Professional Accountant designation at Deloitte.

Duncan Gordon

Chief Operating Officer

Duncan is the former head of manufacturing and supply chain management at Kudu Industries. With over 25 years experience as a manufacturing and supply chain expert, he has led various teams and large-scale projects focused on engineering, procurement, logistics, production and distribution.

Daniel Vass

President & Founder of Natural Health Services Ltd.

Daniel is the founder and President of Natural Health Services (NHS), which operates boutique cannabis clinics across Canada with thousands of patients and growing. The NHS focuses on fulfilling underserved patient needs and educating on the importance of access to a physician-approved environment. NHS is a medical-centric corporation offering quality patient care, superior service and improved quality of life for its patients. NHS is grower-agnostic, choosing the finest products available at the best possible price.

Benjamin Rootman

VP, Legal, Compliance & Regulatory Affairs & Corporate Secretary

Ben is responsible for managing all aspects of the Company’s legal, compliance and regulatory functions and acts as Corporate Secretary to the Board of Directors. Previously, he was General Counsel and Corporate Secretary of Walton International Group Inc. (“WIGI”) from January 2017 to August 2017. Prior thereto, he held the role Chief Compliance Officer and Vice President, Law for Walton Capital Management Inc., a registered exempt market dealer, from July 2014 to January 2017 and the role of Legal Counsel for WIGI from July 2012 to July 2014. Before joining the Walton Group, he was an Associate at Burstall Winger Zammit LLP, focusing on corporate and securities law.

Better Governance

Sunniva’s Board Of Directors

Dr. Anthony Holler

Chairman and CEO

Dr. Anthony (Tony) Holler is the former CEO and founder of ID Biomedical, acquired in 2015 by Glaxo Smith Kline for $1.7 billion, and former Chairman of Corriente Resources Inc., sold for approximately $700 million to CRCC-Tongguan Investment Co. Tony is the current Chairman of CRH Medical Corp., a publicly traded company and serves as Sunniva’s Chief Executive Officer. His expertise includes strategic planning, mergers and acquisitions, and financing, with a singular focus on increasing shareholder value.

Daniel Vass

President & Founder of Natural Health Services Ltd. & Director

Daniel is the founder and CEO of NHS, which operates boutique cannabis clinics across Canada with thousands of patients and growing. The NHS focuses on fulfilling underserved patient needs and educating on the importance of access to a physician-approved environment. NHS is a medical-centric corporation offering quality patient care, superior service and improved quality of life for its patients. NHS is grower-agnostic, choosing the finest products available at the best possible price.

Leith Pedersen

Co-Founder, President, Chief Strategy Officer & Director

As the former owner and CEO of Vida Wealth Management Bahamas, former investment advisor at Canaccord Wealth Management, and former partner at an Alberta brokerage firm managing capital in excess of $3 billion, Leith has a proven track record for success. He lends his expertise in corporate strategy, financing, and sourcing potential mergers and acquisitions as the company’s Chief Strategy Officer.

Michael Barker

Director

Founder of Barker Pacific Group, a firm of experienced real estate professionals active in the acquisition, development, construction management, and asset management of major commercial projects. Founded in 1983, the company specializes in the development and acquisition of institutional-quality office, industrial, and residential projects. As a developer, BPG has completed, developed, or redeveloped in excess of $2.5 billion in commercial projects. The company enjoys close relationships with major corporate and institutional partners who commend the Barker Pacific Group management team's commitment to excellence, entrepreneurial vision, business acumen, and personal integrity.

Luke Stanton

Director

Luke Stanton is an attorney and founder of the Frontera Law Group, a leading firm in the state of California focused on issues related to medical cannabis, which represents a host of quality cannabis companies, brands, products and ancillary service providers. Luke is also a general partner at Skytree Capital Partners, a Nevada-based private equity firm focused on the legal cannabis space. He has been featured in Financial Times Magazine, the National Marijuana News, mg Magazine, Cannabis Industry Journal, MJINews, LEFAIR Magazine and Merry Jane, and has made speaking appearances at numerous cannabis and investment conferences, summits and events across the country.

Ian Webb

Director (Independent)

Former director of ID Biomedical and current director of CRH Medical Corp. Also, former senior corporate law partner of Borden Ladner Gervais LLP, one of Canada’s largest law firms, whose practice encompassed mergers and acquisitions as well as corporate and securities law with an emphasis on the legal requirements of public companies and their boards.

Norm Mayr

Director (Independent)

Norm Mayr is a recently retired (2016) Audit Partner having spent 38 years in public practice with KPMG. He was the Risk Management and Professional Practice Partner for the Greater Vancouver Area practice of KPMG for the most recent 18 years of his career. In this role, Norm was consulted regularly on complex financial reporting, accounting, audit, and securities issues. Norm has extensive experience in the mining, forestry, technology, retail and industrial markets sectors and he served as lead partner on many of KPMG’s largest multinational clients in these industries. He was a founding member of the CICA Accounting Standards Board, and a member of the Canadian Advisory Group to the International Accounting Standards Committee.

Todd R. Patrick

Lead Director (Independent)

Todd brings 30 years of senior executive experience in building health care companies from the ground up. With expertise in finance, intellectual property, strategy and leadership, Todd has been involved with several start-ups as either CEO or as an active investor/board member. In these positions, Todd has helped raise over $600 million in equity/debt capital and participated in several merger and acquisition transactions. Todd is currently the President and CEO of C3J Therapeutics, Inc., a Los Angeles-based biotechnology company where he has raised over $125 million in equity capital. Prior to joining C3J, Todd spent 11 years as President of ID Biomedical until its $1.7 billion acquisition by GlaxoSmithKline.

Dr. Anthony Holler

Chairman and CEO

Dr. Anthony (Tony) Holler is the former CEO and founder of ID Biomedical, acquired in 2015 by Glaxo Smith Kline for $1.7 billion, and former Chairman of Corriente Resources Inc., sold for approximately $700 million to CRCC-Tongguan Investment Co. Tony is the current Chairman of CRH Medical Corp., a publicly traded company and serves as Sunniva’s Chief Executive Officer. His expertise includes strategic planning, mergers and acquisitions, and financing, with a singular focus on increasing shareholder value.

Leith Pedersen

Co-Founder, President, Chief Strategy Officer & Director

As the former owner and CEO of Vida Wealth Management Bahamas, former investment advisor at Canaccord Wealth Management, and former partner at an Alberta brokerage firm managing capital in excess of $3 billion, Leith has a proven track record for success. He lends his expertise in corporate strategy, financing, and sourcing potential mergers and acquisitions as the company’s Chief Strategy Officer.

Ian Webb

Director (Independent)

Former director of ID Biomedical and current director of CRH Medical. Also former senior corporate law partner of Borden Ladner Gervais LLP, one of Canada’s largest law firms, whose practice encompassed mergers and acquisitions as well as corporate and securities law with an emphasis on the legal requirements of public companies and their boards.

Daniel Vass

President & Founder of Natural Health Services Ltd. & Director

Daniel is the founder and CEO of NHS, which operates boutique cannabis clinics across Canada with thousands of patients and growing. The NHS focuses on fulfilling underserved patient needs and educating on the importance of access to a physician-approved environment. NHS is a medical-centric corporation offering quality patient care, superior service and improved quality of life for its patients. NHS is grower-agnostic, choosing the finest products available at the best possible price.

Michael Barker

Director

Founder of Barker Pacific Group, a firm of experienced real estate professionals active in the acquisition, development, construction management, and asset management of major commercial projects. Founded in 1983, the company specializes in the development and acquisition of institutional-quality office, industrial, and residential projects. As a developer, BPG has completed, developed, or redeveloped in excess of $2.5 billion in commercial projects. The company enjoys close relationships with major corporate and institutional partners who commend the Barker Pacific Group management team's commitment to excellence, entrepreneurial vision, business acumen, and personal integrity.

Norm Mayr

Director (Independent)

Norm Mayr is a recently retired (2016) Audit Partner having spent 38 years in public practice with KPMG. He was the Risk Management and Professional Practice Partner for the Greater Vancouver Area practice of KPMG for the most recent 18 years of his career. In this role, Norm was consulted regularly on complex financial reporting, accounting, audit, and securities issues. Norm has extensive experience in the mining, forestry, technology, retail and industrial markets sectors and he served as lead partner on many of KPMG’s largest multinational clients in these industries. He was a founding member of the CICA Accounting Standards Board, and a member of the Canadian Advisory Group to the International Accounting Standards Committee.

Luke Stanton

Director

Luke Stanton is an attorney and founder of the Frontera Law Group, a leading firm in the state of California focused on issues related to medical cannabis, which represents a host of quality cannabis companies, brands, products and ancillary service providers. Luke is also a general partner at Skytree Capital Partners, a Nevada-based private equity firm focused on the legal cannabis space. He has been featured in Financial Times Magazine, the National Marijuana News, mg Magazine, Cannabis Industry Journal, MJINews, LEFAIR Magazine and Merry Jane, and has made speaking appearances at numerous cannabis and investment conferences, summits and events across the country.

Todd R. Patrick

Lead Director (Independent)

Todd brings 30 years of senior executive experience in building health care companies from the ground up. With expertise in finance, intellectual property, strategy and leadership, Todd has been involved with several start-ups as either CEO or as an active investor/board member. In these positions, Todd has helped raise over $600 million in equity/debt capital and participated in several merger and acquisition transactions. Todd is currently the President and CEO of C3J Therapeutics, Inc., a Los Angeles-based biotechnology company where he has raised over $125 million in equity capital. Prior to joining C3J, Todd spent 11 years as President of ID Biomedical until its $1.7 billion acquisition by GlaxoSmithKline.